Molecular Partners

Company Profile

A privately-owned bio-pharmaceutical company, Molecular Partners is pioneering the development of a novel class of targeted protein therapeutics termed DARPins, which are as target-specific and potent as monoclonal antibodies.

Company Info

  • HQ: Zurich, Switzerland
Founders and CEO:
  • Christian Zahnd
Index Team:
Website:
molecularpartners.com
Sector:
Healthcare
Status:
Current